Skip to content
MedsAcross

Medicine

Ibu 800 mg tablet

Ibuprofen · Oral · Dr. Reddy's Laboratories
Available on requestPrescription onlyUS FDAIndian manufacturer

Ibu 800 mg tablet is a prescription medicine containing Ibuprofen for oral use, marketed by Dr. Reddy's Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at room temperature. Avoid excessive heat 40°C (104°F).

Key facts

Active ingredient (INN)
Ibuprofen
Brand
Ibu
Strength
800 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 90 tablets and 15 more
Marketing authorisation holder
Dr. Reddy's Laboratories
Manufacturers
Dr. Reddy's LaboratoriesIndiaAphena Pharma Solutions - TennesseeNuCare Pharmaceuticals,Inc
Origin register
US FDA, United States
Storage
Store at room temperature. Avoid excessive heat 40°C (104°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01EB16 Ibuprofen
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
14 November 2001
Identifiers
RxCUI 197807, 206917, 197805 +3DailyMed set ID 678e2d16-33f3-67a7-e053-2991aa0a1132, ffec2f44-1144-4729-b43a-1db40ea6a8d3, 24731405-219c-79b4-ecf0-7d5fbfda94ba +2NDC 68071-3053, 71610-275, 55111-684 +2Application ANDA075682

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
100 tablet in 1 bottle55111-684-01Dr. Reddy's LaboratoriesIndia20 November 2008
500 tablet in 1 bottle55111-684-05Dr. Reddy's LaboratoriesIndia20 November 2008
90 tablet in 1 bottle55111-684-09Dr. Reddy's LaboratoriesIndia20 November 2008
30 tablet in 1 bottle55111-684-30Dr. Reddy's LaboratoriesIndia20 November 2008
50 tablet in 1 bottle55111-684-50Dr. Reddy's LaboratoriesIndia20 November 2008
60 tablet in 1 bottle55111-684-60Dr. Reddy's LaboratoriesIndia20 November 2008
90 tablet in 1 bottle71610-275-60Aphena Pharma Solutions - Tennessee8 May 2019
180 tablet in 1 bottle71610-275-80Aphena Pharma Solutions - Tennessee8 May 2019
270 tablet in 1 bottle71610-275-92Aphena Pharma Solutions - Tennessee8 May 2019
90 tablet in 1 bottle71610-550-60Aphena Pharma Solutions - Tennessee1 May 2021
180 tablet in 1 bottle71610-550-80Aphena Pharma Solutions - Tennessee1 May 2021
270 tablet in 1 bottle71610-550-92Aphena Pharma Solutions - Tennessee1 May 2021
100 tablet in 1 bottle66267-963-00NuCare Pharmaceuticals,Inc15 September 2017
12 tablet in 1 bottle68071-3053-0NuCare Pharmaceuticals,Inc16 March 2018
120 tablet in 1 bottle68071-3053-1NuCare Pharmaceuticals,Inc16 March 2018
20 tablet in 1 bottle68071-3053-2NuCare Pharmaceuticals,Inc16 March 2018
40 tablet in 1 bottle68071-3053-4NuCare Pharmaceuticals,Inc16 March 2018
60 tablet in 1 bottle68071-3053-6NuCare Pharmaceuticals,Inc16 March 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 September 1974Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ibuprofen 800 mg tablet.

Compare 1

Other strengths and forms of Ibuprofen

Clinical summary

Ibuprofen is a nonsteroidal anti-inflammatory drug indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g,, among other approved uses. MedsAcross supplies Ibuprofen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ibuprofen

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ibu 800 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.